Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. (Record no. 8705971)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02386 a2200649 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513093311.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199609s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0732-183X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1200/JCO.1996.14.8.2353 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Gill, P S |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19960906 |
245 00 - TITLE STATEMENT | |
Title | Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Date of publication, distribution, etc. | Aug 1996 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2353-64 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Acquired Immunodeficiency Syndrome |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Alopecia |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibiotics, Antineoplastic |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bleomycin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Canada |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Daunorubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Doxorubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Carriers |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liposomes |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neutropenia |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Remission Induction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sarcoma, Kaposi |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Failure |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | United States |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vincristine |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wernz, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Scadden, D T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cohen, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mukwaya, G M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | von Roenn, J H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jacobs, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kempin, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Silverberg, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gonzales, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rarick, M U |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Myers, A M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shepherd, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sawka, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pike, M C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ross, M E |
773 0# - HOST ITEM ENTRY | |
Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Related parts | vol. 14 |
-- | no. 8 |
-- | p. 2353-64 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.1996.14.8.2353">https://doi.org/10.1200/JCO.1996.14.8.2353</a> |
Public note | Available from publisher's website |
No items available.